Dr. McDermott is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9000 Rockville Pike
Bldg 10
Bethesda, MD 20892Phone+1 301-496-8483Fax+1 301-402-4369
Education & Training
- National Institutes of Health Clinical CenterFellowship, Infectious Disease, 1998
- University of Virginia Medical CenterInternship, Internal Medicine, 1995 - 1996
- University of Virginia Medical CenterResidency, Internal Medicine, 1992 - 1995
- University of Virginia School of MedicineClass of 1992
Certifications & Licensure
- MD State Medical License 1995 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Clinical Trials
- Genetic Factors in Atherosclerosis Start of enrollment: 2000 Jun 08
- A Phase I Study of Mozobil in the Treatment of Patients With WHIMS Start of enrollment: 2010 Jan 06
- Plerixafor Versus G-CSF in the Treatment of People With WHIM Syndrome Start of enrollment: 2014 Oct 14
Publications & Presentations
PubMed
- 51 citationsAbsence of mucosal-associated invariant T cells in a person with a homozygous point mutation in MR1.Lauren J. Howson, Wael Awad, Anouk von Borstel, Hui Jing Lim, Hamish E G McWilliam
Science Immunology. 2020-07-24 - 63 citationsCXCR4 antagonist AMD3100 redistributes leukocytes from primary immune organs to secondary immune organs, lung, and blood in miceQian Liu, Zhanzhuo Li, Ji-Liang Gao, Wuzhou Wan, Sundar Ganesan
European Journal of Immunology. 2015-06-01 - 3 citationsWHIM Syndrome-linked CXCR4 mutations drive osteoporosis.Adrienne Anginot, Julie Nguyen, Zeina Abou Nader, Vincent Rondeau, Amélie Bonaud
Nature Communications. 2023-04-12
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: